Search research articles
Contact Us
Filters
Showing results (191-200 of 400) with videos related to
Page
of 40
Sort By:
BMC Cancer
|
June 15, 2023
Molecular and clinical characterization of PTRF in glioma via 1,022 samples
Si Sun, Changlin Yang, Kuanyu Wang, et al.
Chemical Communications (Cambridge, England)
|
June 2, 2018
Anomalous thermally-activated NIR emission of ESIPT modulated Nd-complexes for optical fiber sensing devices
Si-Si Sun, Jian-Hua Zhang, Zheng Wang, et al.
Science Bulletin
|
February 6, 2026
Coordination engineering breaks the inertness of Mn single-atom for ultrafast peracetic acid activation
Yudan Dong, Yang Wang, Zhihui Xie, et al.
Journal of Nanobiotechnology
|
October 14, 2021
Catalytically active gold clusters with atomic precision for noninvasive early intervention of neurotrauma
Yunguang Zhang, Si Sun, Haile Liu, et al.
Thoracic Cancer
|
April 7, 2022
A phase II study of anlotinib combined with etoposide and platinum-based regimens in the first-line treatment of extensive-stage small cell lung cancer
Chang Liu, Jiatao Liao, Xianghua Wu, et al.
Blood Purification
|
February 28, 2019
The Association between Long- and Intra-Dialytic Blood Pressure Variability with All-Cause Mortality in Hemodialysis Patients
Ruoxi Liao, Jiameng Li, Liping Lin, et al.
Cancer Chemotherapy and Pharmacology
|
March 25, 2014
Phase I and pharmacokinetic study of polymeric micelle‑formulated paclitaxel in adult Chinese patients with advanced solid tumors
Fangfang Lv, Junning Cao, Jian Zhang, et al.
Translational Lung Cancer Research
|
May 19, 2020
Hormone receptor expression correlates with EGFR gene mutation in lung cancer in patients with simultaneous primary breast cancer
Zhihuang Hu, Xuan Zou, Shanshan Qin, et al.
Molecular Cancer Therapeutics
|
April 8, 2018
APTO-253 Is a New Addition to the Repertoire of Drugs that Can Exploit DNA BRCA1/2 Deficiency
Cheng-Yu Tsai, Si Sun, Hongying Zhang, et al.
Cell Death & Disease
|
January 19, 2021
MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway
Zhiyu Li, Chenyuan Li, Qi Wu, et al.
Page
of 40
Search research articles
Search
Showing results (191-200 of 400) with videos related to
Sort By:
Page
of 40
BMC Cancer
|
June 15, 2023
Molecular and clinical characterization of PTRF in glioma via 1,022 samples
Si Sun, Changlin Yang, Kuanyu Wang, et al.
Chemical Communications (Cambridge, England)
|
June 2, 2018
Anomalous thermally-activated NIR emission of ESIPT modulated Nd-complexes for optical fiber sensing devices
Si-Si Sun, Jian-Hua Zhang, Zheng Wang, et al.
Science Bulletin
|
February 6, 2026
Coordination engineering breaks the inertness of Mn single-atom for ultrafast peracetic acid activation
Yudan Dong, Yang Wang, Zhihui Xie, et al.
Journal of Nanobiotechnology
|
October 14, 2021
Catalytically active gold clusters with atomic precision for noninvasive early intervention of neurotrauma
Yunguang Zhang, Si Sun, Haile Liu, et al.
Thoracic Cancer
|
April 7, 2022
A phase II study of anlotinib combined with etoposide and platinum-based regimens in the first-line treatment of extensive-stage small cell lung cancer
Chang Liu, Jiatao Liao, Xianghua Wu, et al.
Blood Purification
|
February 28, 2019
The Association between Long- and Intra-Dialytic Blood Pressure Variability with All-Cause Mortality in Hemodialysis Patients
Ruoxi Liao, Jiameng Li, Liping Lin, et al.
Cancer Chemotherapy and Pharmacology
|
March 25, 2014
Phase I and pharmacokinetic study of polymeric micelle‑formulated paclitaxel in adult Chinese patients with advanced solid tumors
Fangfang Lv, Junning Cao, Jian Zhang, et al.
Translational Lung Cancer Research
|
May 19, 2020
Hormone receptor expression correlates with EGFR gene mutation in lung cancer in patients with simultaneous primary breast cancer
Zhihuang Hu, Xuan Zou, Shanshan Qin, et al.
Molecular Cancer Therapeutics
|
April 8, 2018
APTO-253 Is a New Addition to the Repertoire of Drugs that Can Exploit DNA BRCA1/2 Deficiency
Cheng-Yu Tsai, Si Sun, Hongying Zhang, et al.
Cell Death & Disease
|
January 19, 2021
MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway
Zhiyu Li, Chenyuan Li, Qi Wu, et al.
Page
of 40